Medea logo

Army Contracts for Jan. 10, 2022

January 10th, 2022 · Washington, D.C.

Medea Inc., Pleasanton, California, was awarded a $190,100,000 firm-fixed-price contract for diagnostic tests for non-prescription home use for the qualitative detection of protein antigen from the novel coronavirus SARS-CoV-2. Bids were solicited via the internet with three received. Work will be performed in Pleasanton, California, with an estimated completion date of Jan. 24, 2022. Fiscal 2022 CARES Act funds in the amount of $190,100,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W58P05-22-C-0005). (Awarded Jan. 9, 2022)

Original article on the website for the U.S. Department of Defense